Krzysztof Małyszczak
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Krzysztof Małyszczak has a total of 93 co-authors. Here are the top co-authors by number of shared publications:
- Aleksandra Szymczak
Department of Infectious Diseases, Liver Disease and Acquired Immune Deficiencies, Wroclaw Medical University, 50-367 Wroclaw, Poland
4 shared publications - Marek Radkowski
Department of Immunopathology of Infectious and Parasitic Diseases, Medical University of Warsaw, 02-091 Warsaw, Poland
4 shared publications Małgorzata Zalewska
Department of Infectious Diseases, Hepatology and Acquired Immune Deficiencies, Wroclaw Medical University, Wroclaw, Poland
4 shared publications- Tomasz Pawłowski
Department of Psychiatry, Wroclaw Medical University, 50-367 Wroclaw, Poland
4 shared publications Witold Pilecki
Department of Pathophysiology, Wroclaw Medical University, Wroclaw, Poland
4 shared publications- Agata Mikolajkow
Zakład Psychoterapii i Chorób Psychosomatycznych, Katedra Psychiatrii, Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu
3 shared publications
Latest Publications
- Open Access
- 13 February 2024
- Published by Wroclaw Medical University in Advances in Clinical and Experimental Medicine
- Vol. 33 (12) , 1367-1377
Disability and emotional symptoms in women with lipedema: A comparison with overweight/obese women
Lipedema is characterized by the painful abnormal deposition of adipose tissue in the lower limbs and is often misdiagnosed as obesity. Considering the numerous bothersome physical symptoms of lipedema, women with lipedema may have greater disability and emotional problems than women with lifestyle-induced obesity. Our study aims to assess disability, anxiety and depression symptoms in women with lipedema compared to women with overweight/obesity. Women with lipedema (n = 45, with a mean age of 41 years) and women who are overweight/obese (n = 43, with a mean age of 44.95 years) were asked to complete the following questionnaires: The World Health Organization Disability Assessment Schedule (WHO-DAS II), Beck's Depression Inventory - II (BDI-II), and The Hospital Anxiety and Depression Scale (HADS). Despite the higher BMI in the overweight/obesity group, the group with lipedema was more disabled in numerous domains of the WHO-DAS II questionnaire, including Life activities - domestic, work and school responsibilities and Participation in society When the influence of BMI was adjusted, a difference in the domain of Mobility was also present. The study groups did not differ in anxiety and depression symptoms. We showed that behavioral impairment was the main factor affecting functioning in women with lipedema. Emotional symptoms did not differentiate the study groups. Leg volumes and adipose tissue pain intensity were associated with greater disability in women with lipedema, and should be considered in managing women with this condition and in future research estimating the effectiveness of lipedema treatment.
- 13 February 2024
- Published by Wroclaw Medical University in Advances in Clinical and Experimental Medicine
- Vol. 33 (12) , 1367-1377
Open AccessDisability and emotional symptoms in women with lipedema: A comparison with overweight/obese women
Lipedema is characterized by the painful abnormal deposition of adipose tissue in the lower limbs and is often misdiagnosed as obesity. Considering the numerous bothersome physical symptoms of lipedema, women with lipedema may have greater disability and emotional problems than women with lifestyle-induced obesity. Our study aims to assess disability, anxiety and depression symptoms in women with lipedema compared to women with overweight/obesity. Women with lipedema (n = 45, with a mean age of 41 years) and women who are overweight/obese (n = 43, with a mean age of 44.95 years) were asked to complete the following questionnaires: The World Health Organization Disability Assessment Schedule (WHO-DAS II), Beck's Depression Inventory - II (BDI-II), and The Hospital Anxiety and Depression Scale (HADS). Despite the higher BMI in the overweight/obesity group, the group with lipedema was more disabled in numerous domains of the WHO-DAS II questionnaire, including Life activities - domestic, work and school responsibilities and Participation in society When the influence of BMI was adjusted, a difference in the domain of Mobility was also present. The study groups did not differ in anxiety and depression symptoms. We showed that behavioral impairment was the main factor affecting functioning in women with lipedema. Emotional symptoms did not differentiate the study groups. Leg volumes and adipose tissue pain intensity were associated with greater disability in women with lipedema, and should be considered in managing women with this condition and in future research estimating the effectiveness of lipedema treatment.
- Open Access
- 14 September 2023
- Published by Institute of Rural Health in Journal of Pre-Clinical and Clinical Research
- Vol. 17 (3) , 121-126
The relationship between biological factors (vitamin D, prolactin, oxytocin, thyroid hormones) , Pregnancy-Related Anxiety and Maternal-Foetal Attachment
Introduction and objective: Pregnancy-Related Anxiety (PrA) is a common issue in pregnancy, which is distinctive from Generalized Anxiety Disorder. It has numerous negative outcomes for both mother and child. The aim of this study was to investigate the relationship between vitamin D, thyroid...
- 14 September 2023
- Published by Institute of Rural Health in Journal of Pre-Clinical and Clinical Research
- Vol. 17 (3) , 121-126
Open AccessThe relationship between biological factors (vitamin D, prolactin, oxytocin, thyroid hormones) , Pregnancy-Related Anxiety and Maternal-Foetal Attachment
Introduction and objective: Pregnancy-Related Anxiety (PrA) is a common issue in pregnancy, which is distinctive from Generalized Anxiety Disorder. It has numerous negative outcomes for both mother and child. The aim of this study was to investigate the relationship between vitamin D, thyroid...
- Open Access
- 25 May 2023
- Published by Institute of Rural Health in Journal of Pre-Clinical and Clinical Research
Awareness of prenatal anxiety disorders among Obstetricians and General Practitioners in Poland – A cross-sectional study
Introduction: Mental health disorders are more prevalent in pregnancy than in the general population. Anxiety disorders in pregnancy, particularly Pregnancy-Related Anxiety (PrA) have multiple negative consequences for the mother and her child. Pregnant patients have multiple visits with their...
- 25 May 2023
- Published by Institute of Rural Health in Journal of Pre-Clinical and Clinical Research
Open AccessAwareness of prenatal anxiety disorders among Obstetricians and General Practitioners in Poland – A cross-sectional study
Introduction: Mental health disorders are more prevalent in pregnancy than in the general population. Anxiety disorders in pregnancy, particularly Pregnancy-Related Anxiety (PrA) have multiple negative consequences for the mother and her child. Pregnant patients have multiple visits with their...
- Open Access
HTR1A, TPH2, and 5-HTTLPR Polymorphisms and Their Impact on the Severity of Depressive Symptoms and on the Concentration of Tryptophan Catabolites during Hepatitis C Treatment with Pegylated Interferon-α2a and Oral Ribavirin (PEG-IFN-α2a/RBV)
Background: Seeing that there are no data about associations between serotonin gene polymorphism and tryptophan catabolite concentration during PEG-IFN-α2a treatment, the aim of the current study is to examine (a) the associations between polymorphisms within the HTR1A, TPH2, and 5-HTT genes and the severity of depression symptoms and (b) the relationships among rs6295, rs4570625, and 5-HTTLPR rs25531polymorphisms and indoleamine 2,3-dioxygenase (IDO) activity, as well as kynurenine (KYN), tryptophan (TRP), kynurenic acid (KA), and anthranilic acid (AA) concentrations. Materials and methods: The study followed a prospective, longitudinal, single-center cohort design. The severity of the depressive symptoms of 101 adult patients with chronic HCV infections was measured during PEG-IFN-α2a/RBV treatment. We used the Montgomery–Åsberg Depression Rating Scale (MADRS) to assess the severity of depressive symptoms. The subjects were evaluated six times—at baseline and at weeks 2, 4, 8, 12, and 24. At all the time points, MADRS score, as well as KYN, TRP, KA, and AA concentrations, and IDO activity were measured. At baseline, rs6295, rs4570625, and 5-HTTLPR rs25531polymorphisms were assessed. Results: Subjects with C/C genotypes of 5-HT1A and lower-expressing alleles (S/S, LG/LG, and S/LG) of 5-HTTLPR scored the highest total MADRS scores and recorded the highest increase in MADRS scores during treatment. We found associations between TRP concentrations and the TPH-2 and 5-HTTLPR rs25531 genotypes. Conclusions: Our findings provide new data that we believe can help better understand infection-induced depression as a distinct type of depression.
Open AccessHTR1A, TPH2, and 5-HTTLPR Polymorphisms and Their Impact on the Severity of Depressive Symptoms and on the Concentration of Tryptophan Catabolites during Hepatitis C Treatment with Pegylated Interferon-α2a and Oral Ribavirin (PEG-IFN-α2a/RBV)
Background: Seeing that there are no data about associations between serotonin gene polymorphism and tryptophan catabolite concentration during PEG-IFN-α2a treatment, the aim of the current study is to examine (a) the associations between polymorphisms within the HTR1A, TPH2, and 5-HTT genes and the severity of depression symptoms and (b) the relationships among rs6295, rs4570625, and 5-HTTLPR rs25531polymorphisms and indoleamine 2,3-dioxygenase (IDO) activity, as well as kynurenine (KYN), tryptophan (TRP), kynurenic acid (KA), and anthranilic acid (AA) concentrations. Materials and methods: The study followed a prospective, longitudinal, single-center cohort design. The severity of the depressive symptoms of 101 adult patients with chronic HCV infections was measured during PEG-IFN-α2a/RBV treatment. We used the Montgomery–Åsberg Depression Rating Scale (MADRS) to assess the severity of depressive symptoms. The subjects were evaluated six times—at baseline and at weeks 2, 4, 8, 12, and 24. At all the time points, MADRS score, as well as KYN, TRP, KA, and AA concentrations, and IDO activity were measured. At baseline, rs6295, rs4570625, and 5-HTTLPR rs25531polymorphisms were assessed. Results: Subjects with C/C genotypes of 5-HT1A and lower-expressing alleles (S/S, LG/LG, and S/LG) of 5-HTTLPR scored the highest total MADRS scores and recorded the highest increase in MADRS scores during treatment. We found associations between TRP concentrations and the TPH-2 and 5-HTTLPR rs25531 genotypes. Conclusions: Our findings provide new data that we believe can help better understand infection-induced depression as a distinct type of depression.
- Open Access
- 31 December 2022
- Published by Komitet Redakcyjno - Wydawniczy Polskiego Towarzystwa Psychiatrycznego in Psychiatria Polska
- Vol. 56 (6) , 1289-1314
Biological factors and consequences of pregnancy-related anxiety – What do we know so far?
Tło: Zdrowie psychiczne pacjentek w ciąży stało się przedmiotem zainteresowania klinicystów, jednak zaburzenia lękowe w ciąży są nadal niedostrzegane i niedodiagnozowane, pomimo ich udowodnionego związku z niekorzystnymi wynikami porodowymi. Cel: Celem niniejszego badania przeglądowego jest podsumowanie aktualnej wiedzy na temat czynników biologicznych PrA (Pregnancy-Related Anxiety, Zaburzenia Lękowe Specyficzne dla Ciąży) i najczęstszych skutków, zarówno dla matki, jak i dziecka, a tym samym wskazanie najważniejszych problemów i zasugerowanie przebiegu dalszych badań w tej dziedzinie. Metody: Dokonaliśmy przeglądu literatury, korzystając z PubMed. Wyniki: Naukowcy wykazali istotny związek pomiędzy lękiem występującym w ciąży a zmianami poziomu hormonów. Te zmiany obejmują między innymi: regulację osi HPA, funkcje tarczycy, poziom oksytocyny, prolaktyny czy progesteronu. Dyskusja: Udowodniono, że PrA jest zaburzeniem wieloczynnikowym. Z jego występowaniem korelują liczne czynniki psychologiczne, jak np. niewystarczające wsparcie społeczne, nieplanowana ciąża, brak aktywności fizycznej czy wysoki poziom stresu. Pomimo iż ciąża jest znaczącą zmianą w życiu człowieka i może być bardzo stresującym wydarzeniem, założenie, że klinicznie istotny lęk prenatalny należy tłumaczyć tylko czynnikami psychologicznymi, wydaje się niewystarczające. Wnioski: Zaburzenia lękowe specyficzne dla ciąży (PrA) są powszechnym zaburzeniem zdrowia psychicznego w ciąży i potrzebne są dalsze badania, aby zminimalizować ryzyko jego poważnych konsekwencji.
- 31 December 2022
- Published by Komitet Redakcyjno - Wydawniczy Polskiego Towarzystwa Psychiatrycznego in Psychiatria Polska
- Vol. 56 (6) , 1289-1314
Open AccessBiological factors and consequences of pregnancy-related anxiety – What do we know so far?
Tło: Zdrowie psychiczne pacjentek w ciąży stało się przedmiotem zainteresowania klinicystów, jednak zaburzenia lękowe w ciąży są nadal niedostrzegane i niedodiagnozowane, pomimo ich udowodnionego związku z niekorzystnymi wynikami porodowymi. Cel: Celem niniejszego badania przeglądowego jest podsumowanie aktualnej wiedzy na temat czynników biologicznych PrA (Pregnancy-Related Anxiety, Zaburzenia Lękowe Specyficzne dla Ciąży) i najczęstszych skutków, zarówno dla matki, jak i dziecka, a tym samym wskazanie najważniejszych problemów i zasugerowanie przebiegu dalszych badań w tej dziedzinie. Metody: Dokonaliśmy przeglądu literatury, korzystając z PubMed. Wyniki: Naukowcy wykazali istotny związek pomiędzy lękiem występującym w ciąży a zmianami poziomu hormonów. Te zmiany obejmują między innymi: regulację osi HPA, funkcje tarczycy, poziom oksytocyny, prolaktyny czy progesteronu. Dyskusja: Udowodniono, że PrA jest zaburzeniem wieloczynnikowym. Z jego występowaniem korelują liczne czynniki psychologiczne, jak np. niewystarczające wsparcie społeczne, nieplanowana ciąża, brak aktywności fizycznej czy wysoki poziom stresu. Pomimo iż ciąża jest znaczącą zmianą w życiu człowieka i może być bardzo stresującym wydarzeniem, założenie, że klinicznie istotny lęk prenatalny należy tłumaczyć tylko czynnikami psychologicznymi, wydaje się niewystarczające. Wnioski: Zaburzenia lękowe specyficzne dla ciąży (PrA) są powszechnym zaburzeniem zdrowia psychicznego w ciąży i potrzebne są dalsze badania, aby zminimalizować ryzyko jego poważnych konsekwencji.
- 4 August 2022
- Published by Elsevier in Journal of Psychosomatic Research
- Vol. 161, 110999
The circadian rhythm of blood pressure in patients with panic disorder and generalized anxiety disorder
- 4 August 2022
- Published by Elsevier in Journal of Psychosomatic Research
- Vol. 161, 110999
The circadian rhythm of blood pressure in patients with panic disorder and generalized anxiety disorder
- Open Access
High-frequency changes in single-trial visual evoked potentials for unattended stimuli in chronic schizophrenia
Background Patients with schizophrenia reveal changes in information processing associated with external stimuli, which is reflected in the measurements of brain evoked potentials. We discuss actual knowledge on electro- (EEG) and magnetoencephalographic (MEG) changes in schizophrenia. New method The commonly used averaging technique entails the loss of information regarding the generation of evoked responses. We propose a methodology to describe single-trial (non-averaged) visual evoked potentials (VEP) using spectral and statistical analyses. We analysed EEG data registered in the O1-Cz and O2-Cz leads during unattended pattern-reversal stimulation, collected from a group of adult patients with chronic schizophrenia, and compared them to those of healthy individuals. Short-time single-trial VEP were transformed to the frequency domain using the FFT algorithm. Changes of the spectral power were visualized using spectrograms which were created by stacking single-trial spectra across all trials. Measures of the absolute and the relative spectral power were calculated and compared statistically. Results In schizophrenia, the energy density of VEP oscillations is shifted towards higher (gamma) frequencies, compared to healthy individuals. These differences are statistically significant in all analysed frequency bands for the relative power. This indicates distorted early processing of visual stimuli in schizophrenia. Comparison with existing methods The main advantage of the presented methodology is its simplicity and ease of interpretation of obtained results. The presented observations complement the knowledge on gamma oscillations acquired from computationally more complex methods of time–frequency analysis. Conclusions High-frequency changes for single-trial VEPs are detected in chronic schizophrenia.
Open AccessHigh-frequency changes in single-trial visual evoked potentials for unattended stimuli in chronic schizophrenia
Background Patients with schizophrenia reveal changes in information processing associated with external stimuli, which is reflected in the measurements of brain evoked potentials. We discuss actual knowledge on electro- (EEG) and magnetoencephalographic (MEG) changes in schizophrenia. New method The commonly used averaging technique entails the loss of information regarding the generation of evoked responses. We propose a methodology to describe single-trial (non-averaged) visual evoked potentials (VEP) using spectral and statistical analyses. We analysed EEG data registered in the O1-Cz and O2-Cz leads during unattended pattern-reversal stimulation, collected from a group of adult patients with chronic schizophrenia, and compared them to those of healthy individuals. Short-time single-trial VEP were transformed to the frequency domain using the FFT algorithm. Changes of the spectral power were visualized using spectrograms which were created by stacking single-trial spectra across all trials. Measures of the absolute and the relative spectral power were calculated and compared statistically. Results In schizophrenia, the energy density of VEP oscillations is shifted towards higher (gamma) frequencies, compared to healthy individuals. These differences are statistically significant in all analysed frequency bands for the relative power. This indicates distorted early processing of visual stimuli in schizophrenia. Comparison with existing methods The main advantage of the presented methodology is its simplicity and ease of interpretation of obtained results. The presented observations complement the knowledge on gamma oscillations acquired from computationally more complex methods of time–frequency analysis. Conclusions High-frequency changes for single-trial VEPs are detected in chronic schizophrenia.
- 1 April 2019
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 399, 36-43
Evaluation of brain volume alterations in HCV-infected patients after interferon-free therapy: A pilot study
- 1 April 2019
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 399, 36-43
Evaluation of brain volume alterations in HCV-infected patients after interferon-free therapy: A pilot study
- Open Access
- 27 February 2019
- Published by Wroclaw Medical University in Advances in Clinical and Experimental Medicine
- Vol. 28 (9) , 1217-1222
Biological and psychological components of depression in patients receiving IFN-alpha therapy for hepatitis C
Depressive symptoms are frequent side effects of interferon α therapy (IFN-α). Both biological and psychological processes may occur concomitantly during hepatitis C treatment. This study was carried out to determine the impact of biological (immune response) and psychological factors on formation of depressive symptoms and major depressive disorder (MDD) during hepatitis C treatment. A total of 99 patients receiving pegylated IFN-α and ribavirin for chronic C type hepatitis participated in the prospective cohort study. Symptoms of depression were assessed with the MontgomeryÅsberg Depression Rating Scale (MADRS) during treatment and 24 weeks after treatment. Neuroticism was measured with the Eysenck Personality Questionnaire - Revised (EPQ-R/N). Diagnosis of MDD was made using the Present State Examination (PSE-10) and DSM-IV-TR criteria. Factor analysis was used to detect factors adding up to total severity of depressive symptoms. Predictors of MDD were investigated using logistic regression analysis. Factor analysis returned 3 factors: 1st - MADRS scores at weeks 0-12, 2nd - MADRS and N scores before treatment, 3rd - MADRS at the 24th week of treatment and 24 weeks after treatment. The total severity of depressive symptoms consisted of 3 components: personality-related before treatment, IFN-α-related during treatment and dependent on the effect of treatment. Regression analysis showed that a history of psychiatric disorders (OR = 4.8) and MADRS scores before treatment (OR = 1.25) were predictors of MDD, as opposed to level of neuroticism. The severity of depressive symptoms and MDD during the hepatitis C treatment was related to general depressive vulnerability, not to psychological factors related to neuroticism.
- 27 February 2019
- Published by Wroclaw Medical University in Advances in Clinical and Experimental Medicine
- Vol. 28 (9) , 1217-1222
Open AccessBiological and psychological components of depression in patients receiving IFN-alpha therapy for hepatitis C
Depressive symptoms are frequent side effects of interferon α therapy (IFN-α). Both biological and psychological processes may occur concomitantly during hepatitis C treatment. This study was carried out to determine the impact of biological (immune response) and psychological factors on formation of depressive symptoms and major depressive disorder (MDD) during hepatitis C treatment. A total of 99 patients receiving pegylated IFN-α and ribavirin for chronic C type hepatitis participated in the prospective cohort study. Symptoms of depression were assessed with the MontgomeryÅsberg Depression Rating Scale (MADRS) during treatment and 24 weeks after treatment. Neuroticism was measured with the Eysenck Personality Questionnaire - Revised (EPQ-R/N). Diagnosis of MDD was made using the Present State Examination (PSE-10) and DSM-IV-TR criteria. Factor analysis was used to detect factors adding up to total severity of depressive symptoms. Predictors of MDD were investigated using logistic regression analysis. Factor analysis returned 3 factors: 1st - MADRS scores at weeks 0-12, 2nd - MADRS and N scores before treatment, 3rd - MADRS at the 24th week of treatment and 24 weeks after treatment. The total severity of depressive symptoms consisted of 3 components: personality-related before treatment, IFN-α-related during treatment and dependent on the effect of treatment. Regression analysis showed that a history of psychiatric disorders (OR = 4.8) and MADRS scores before treatment (OR = 1.25) were predictors of MDD, as opposed to level of neuroticism. The severity of depressive symptoms and MDD during the hepatitis C treatment was related to general depressive vulnerability, not to psychological factors related to neuroticism.
- 1 November 2018
- Published by Elsevier in Psychoneuroendocrinology
- Vol. 97, 1-7
Alterations in the metabolism of tryptophan in patients with chronic hepatitis C six months after pegylated interferon-α 2a treatment
- 1 November 2018
- Published by Elsevier in Psychoneuroendocrinology
- Vol. 97, 1-7
Alterations in the metabolism of tryptophan in patients with chronic hepatitis C six months after pegylated interferon-α 2a treatment